Skip to main content
Equibles

WELLS FARGO & COMPANY/MN

Position in ACHV — Achieve Life Sciences, Inc.

CIK 72971 SAN FRANCISCO, CA
Back to ACHV Full portfolio

Position in ACHV

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,114,233
+$814,439 QoQ
Shares Held
170,633
+67.3% QoQ
Ownership
0.166%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#36
of 111 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 93% Shared 0% None 7%

Common Shares in ACHV Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

WELLS FARGO & COMPANY/MN holds $1,575,562,942 across 417 Biotechnology names. ACHV ranks #130 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 749,528 $372,313,040
2 HALO
Halozyme Therapeutics, Inc.
 1,390,428 $108,828,797
3 ALNY
Alnylam Pharmaceuticals, Inc.
 310,047 $93,333,446
4 REGN
Regeneron Pharmaceuticals, Inc.
 140,802 $87,795,677
5 EXEL
Exelixis, Inc.
 717,840 $39,057,673
6 RVMD
Revolution Medicines, Inc.
 178,780 $33,481,916
7 ARGX
Argenx SE
 34,453 $31,964,458
8 INCY
Incyte Corp
 255,064 $28,914,053

All Filings in ACHV

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,114,233 170,633
2026-03-31 $299,794 101,971
2025-12-31 $348,193 70,059
2025-09-30 $225,527 71,596
2025-06-30 $142,502 63,055
2025-03-31 $198,300 74,270
2024-12-31 $263,763 74,933
2024-09-30 $331,202 69,874
2024-06-30 $356,635 75,880
2024-03-31 $313,062 68,805
2023-12-31 $287,950 69,891
2023-09-30 $520,217 120,981
2023-06-30 $635,738 122,493
2023-03-31 $846,756 124,523
2022-12-31 $308,626 125,970
2022-09-30 $455,294 137,968
2022-06-30 $609,867 124,973
2022-03-31 $42,338 5,593
2021-12-31 $43,513 5,593
2021-09-30 $39,014 4,590
2021-06-30 $8,018 893
2021-03-31 $3,740 323
2020-12-31 $4,406 544
2020-09-30 $2,603 311
2020-06-30 $84 211
2020-03-31 $55 167